STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $182,000 | -28.3% | 37,646 | +57.3% | 0.00% | 0.0% |
Q4 2019 | $254,000 | -33.9% | 23,929 | -19.9% | 0.00% | -66.7% |
Q1 2019 | $384,000 | -10.9% | 29,864 | -34.2% | 0.01% | -25.0% |
Q4 2018 | $431,000 | -12.4% | 45,413 | +48.1% | 0.01% | 0.0% |
Q2 2018 | $492,000 | +154.9% | 30,656 | +148.0% | 0.01% | +166.7% |
Q4 2017 | $193,000 | +20.6% | 12,360 | -33.9% | 0.00% | 0.0% |
Q1 2017 | $160,000 | -40.1% | 18,700 | -25.1% | 0.00% | -40.0% |
Q4 2016 | $267,000 | -51.9% | 24,954 | -51.3% | 0.01% | -50.0% |
Q3 2016 | $555,000 | +46.8% | 51,243 | -8.3% | 0.01% | +25.0% |
Q2 2016 | $378,000 | +62.9% | 55,854 | +12.0% | 0.01% | +60.0% |
Q1 2016 | $232,000 | +46.8% | 49,860 | +272.1% | 0.01% | +66.7% |
Q2 2015 | $158,000 | – | 13,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |